{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:18:49Z","timestamp":1766902729702,"version":"3.32.0"},"reference-count":16,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24042","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T22:15:58Z","timestamp":1732745758000},"page":"313-317","source":"Crossref","is-referenced-by-count":3,"title":["Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma"],"prefix":"10.3960","volume":"64","author":[{"given":"Yotaro","family":"Motomura","sequence":"first","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Yoshifuji","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizuko","family":"Sakashita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Umezawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikage","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Asahina","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol. 2012; 9: 156-166.","DOI":"10.1038\/nrclinonc.2012.1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Manzano-Alonso ML, Castellano-Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol. 2011; 17: 1531-1537.","DOI":"10.3748\/wjg.v17.i12.1531"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Dong HJ, Ni LN, Sheng GF <i>et al.<\/i> Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis. J Clin Virol. 2013; 57: 209-214.","DOI":"10.1016\/j.jcv.2013.03.010"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Torres HA, Hosry J, Mahale P <i>et al.<\/i> Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study. Hepatology. 2018; 67: 36-47.","DOI":"10.1002\/hep.29344"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Mahale P, Kontoyiannis DP, Chemaly RF <i>et al.<\/i> Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012; 57: 1177-1185.","DOI":"10.1016\/j.jhep.2012.07.031"},{"key":"6","unstructured":"6 Japan Society of Hepatology. Guidelines for the management of hepatitis B virus infection. https:\/\/www.jsh.or.jp\/medical\/guidelines\/jsh_guidlines\/hepatitis_b.html."},{"key":"7","unstructured":"7 Japan Society of Hepatology. Guidelines for the management of hepatitis C virus infection. https:\/\/www.jsh.or.jp\/medical\/guidelines\/jsh_guidlines\/hepatitis_c.html."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Gomyo H, Kagami Y, Kato H <i>et al.<\/i> Primary hepatic follicular lymphoma : a case report and discussion of chemotherapy and favorable outcomes. J Clin Exp Hematop. 2007; 47: 73-77.","DOI":"10.3960\/jslrt.47.73"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Szpakowski JL, Tucker LY, Baer DM, Pauly MP. Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study. Can Liver J. 2022; 5: 43-60.","DOI":"10.3138\/canlivj-2021-0018"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Lee HL, Bae SH, Jang B <i>et al.<\/i> Reactivation of hepatitis C virus and its clinical outcomes in patients treated with systemic chemotherapy or immunosuppressive therapy. Gut Liver. 2017; 11: 870-877.","DOI":"10.5009\/gnl16434"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Totani H, Kusumoto S, Tanaka Y <i>et al.<\/i> The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy. Int J Hematol. 2016; 104: 384-391.","DOI":"10.1007\/s12185-016-2033-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ennishi D, Maeda Y, Niitsu N <i>et al.<\/i> Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood. 2010; 116: 5119-5125.","DOI":"10.1182\/blood-2010-06-289231"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kusumoto S, Arcaini L, Hong X <i>et al.<\/i> Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. Blood. 2019; 133: 137-146.","DOI":"10.1182\/blood-2018-04-848044"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Li YR, Hu TH, Chen WC, Hsu PI, Chen HC. Screening and prevention of hepatitis C virus reactivation during chemotherapy. World J Gastroenterol. 2021; 27: 5181-5188.","DOI":"10.3748\/wjg.v27.i31.5181"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Torres HA, Economides MP, Angelidakis G <i>et al.<\/i> Sofosbuvir-based therapy in hepatitis C virus-infected cancer patients: A prospective observational study. Am J Gastroenterol. 2019; 114: 250-257.","DOI":"10.1038\/s41395-018-0383-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 . EASL recommendation on treatment of hepatitis C 2018. J Hepatol. 2018; 69: 461-511.","DOI":"10.1016\/j.jhep.2018.03.026"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/4\/64_24042\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:04:02Z","timestamp":1735362242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/4\/64_24042\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24042","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24042"}}